Within the CLL microenvironment, NLCs and FDCs have been found to express increased levels of BAFF and APRIL, with these ligands inducing NF-κB pathway activation (52, 94). The gene discussed is NFKB1; the disease is B-cell chronic lymphocytic leukemia.